Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Gastrointestinal 3Myeloid 2Lymphoid 2Sarcoma 1Classical hematology 1

Conditions

Colorectal Neoplasms 2Neoplasm Metastasis 1Colorectal Cancer Metastatic 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Maraviroc × Gastrointestinal × Clear all
NCT04721301 2023-10-17

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

University Hospital Heidelberg

Phase 1 Completed
50 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03274804 2022-06-07

PICCASSO

University Hospital Heidelberg

Phase 1 Completed
20 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT01736813 2017-03-22

MARACON

National Center for Tumor Diseases, Heidelberg

Completed
12 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡